Theme: Latest innovations in Hematology

Hematology Congress 2021

Renowned Speakers

Hematology Congress 2021

Hematology Congress 2021 committee are honoured to invite you to join the upcoming “19th World Hematology Congress” on March 15-16, 2021. This congress is predicted to be the most important and best dais for all the Scientists, Haematologists, Oncologists, Pathologists, Surgeons, Nurses, Research Scholars, Business Professionals, Students who are working in the branch of Hematology.

Theme: Breezes of transformation and revolution in Hematology

Hematology Congress 2021 comprise of speaker oral talks, poster presentations, brief keynote presentations, workshops and exhibitions.  Here researchers and associations will exchange ideas and discuss the Management and Care of Patients, new approaches emerging in Hematology and also advanced methodology for Diagnostics and treatment for Hematologic Disorders etc.

CME Accredited Hematologists 2021 are going to be organized by Conference Series Ltd which is comprised of 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences everywhere the world. Conference Series Ltd through its international conferences provides a superb opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.

Why to attend?

Hematology Congress 2021 will provide a scientific environment and a platform for the participants to exchange their views and ideas regarding Hematology research. Researchers and Associations from around the globe focused on learning about Leukemia, Hemophilia, Blood clotting and Hematologic Oncology can involve in collaboration and networking; A great chance to reach a huge assemblage of participants from the Hematology community to fight against these deadly disorders.

Target Audience

  • Hematologists
  • Oncologists
  • Haematopathologists
  • Scientists
  • Young Researchers
  • Medical Students
  • Physicians/Consultants/ General Practitioners
  • Nurses
  • Residents
  • Directors/Managers
  • Pathologists
  • Presidents & Vice Presidents/ Directors / Administrators
  • Business Entrepreneurs
  • Haematology Pharma Companies
  • Medical Devices Companies
  • Hematology Associations/ Societies

Prestigious Award for Young Research's at Hematology Congress 2021 - Discovering New Exploration in Hematology field

Hematology Conference Committee is glad to announce “19th World Hematology Congress” March 15 -16, 2021 by focusing on the theme: “Breezes of transformation and revolution in Hematology”. Hematology Congress 2021 developments are maintaining their momentum. Hematology Conference program delves into strategic discussions.

Hematology Congress 2021 Young Scientist Awards:

Hematology Conference Committee is intended to honour prestigious award for talented Young researchers, scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Hematology.

Young Research’s Awards at Hematology Congress 2021 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at the Hematology Congress 2021 young research forum. .

Guidelines for Young Researchers Forum

Benefits

Young Scientist Award recognition certificate and memento to the winners.

Our conferences provide best Platform for your research through oral presentations.

Learn about career improvement with all the latest technologies by networking.

Young Scientists will get appropriate and timely information by this Forum.

Platform for collaboration among young researchers for better development.

Provide an opportunity for research interaction and established senior investigators across the globe in the field.

Share the ideas with both eminent researchers and mentors.

It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

Eligibility

Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty with a minimum of 5 years of research experience

Presentation must be into scientific sessions of the conference.

Each Young Researcher / Young Scientist can submit only one paper (as first author or co-author).

Age limit-Under 35yrs

All submissions must be in English.

Sessions & Tracks:

Track 1: Hematology and Cardio-Oncology

Cardiovascular problems via blood and therefore the system that gives laboratory values regarding blood, the circulatory system and secures cardiovascular diseases from the Chinese medicine and western medicine perspectives. Cardio-Oncology is to seek out a balance between oncologic efficacy and reducing antagonistic cardiovascular effects over timely publication and broadcasting of research. Cardiac imaging and transthoracic echocardiography play an important role within the baseline assessment and serial follow-up of cardio-oncology patients. Scientific indication in the administration of cardiovascular hitches of onco-hematological patients is unusual, as these patients have been systematically omitted from clinical trials and up-to-date approvals are based on expert consent. Cardio-onco-hematology which permit its claim in regular clinical preparation so to market the expansion of local multidisciplinary crews, to rally the cardiovascular health of patients with cancer.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

 American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for   Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 2: Vascular Bleeding Disorders

Haemorrhage disorders are instigated by vascular malformation or impairment. They are linked with cutaneous or mucosal flat or palpable purpura. These disorders are a heterogeneous assembly of circumstances categorized by easy staining, petechiae, mucosal bleeding, ecchymosis, and impulsive bleeding from small vessels. The fundamental imperfection is stated to be moreover in the vessels themselves or in the perivascular connective tissue. Worth mentioning, the commonly used “purpura” is usually describe subcutaneous bleeding, which will be linked to vessel wall abnormalities (described here) or platelet abnormalities. Of which some are hereditary and while the others are acquired

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

 American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for   Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 3: Neuro-hematology

The crossing point amongst hematology and neurology is comprehensive, and neurological complications within the course of hematologic ailment are recurrent and diverse. Polycythemia, in which there are increased numbers of red blood cells with iron deficient. Polycythemia and therefore the comparative Sideropenia cause amplified blood viscosity with connected neurological symptoms and signs. Haematological conditions that lead into neurological manifestations are Thrombophilia, antiphospholipid antibody syndrome, thrombotic thrombocytopenic purpura, sickle cell, myeloma, leukemias, lymphomas and clonal disorders. These are considered into benign and malignant situations.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

  American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 4: Transfusion Medicines

Blood Transfusion is a medical practice where donated blood is transfused to a recipient. It is a lifesaving, benign procedure. These are wont to treat several medical conditions like iron deficiency Anemia, red blood cell ailment, severe haemorrhage generally from surgery, childbirth, or a significant fate. What is more whole blood or blood components (red blood cells, white blood cells, plasma and clotting factors) are castoff depending on the state of the patient. For the rationale that high-end medical involvements, the demand for blood and blood components is increasing steadily everywhere the planet. The mandate for blood is progressively growing albeit some branches of drugs have brought down its inevitability. There will be reform of transfusion facilities for healthier effectiveness and repair delivery. The number of blood banks will drop, and high-volume, technically up-clambered central blood banks will function in their place to diminish the prices of procedure. All together, we predict good scenarios for transfusion medicine specialists by the year 2025, at the best within the developing countries. Transfusion medicine has good prospective R&D approaches in somatic cell Research

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

  American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

 Track 5: Hematology Nursing

Hematology medical attendants are the specialists in taking care of the patients with blood related infections. They realize patients' medical record , and that they will help the hematologist to analyse and treat the blood related illnesses. The most imperative thing is to teach the patients to deal with the illnesses gallantly. They can recommend the prescription as they know about the state of the condition. They conceivably spread their assistance in the transplantation of the blood as well. Keeping in mind the end goal to seek after the learning of hematology nursing, one must finish the recognition in nursing or four year college education in nursing and the massive feeling of certainty happens when they have the involvement in the particular field. Hematology nursing is commonly identified with the hematology oncology.

 Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

 American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for   Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

  Track 6: Case Reports in Hematology

A case report is usually considered a kind of anecdotal proof. Given their intrinsic method limitations, including absence of statistical sampling, case reports are placed at the foot of the hierarchy of clinical proof, beside case series. However, Hematology case reports do have genuinely helpful roles in medical research and evidence-based drugs. Specifically, they have facilitated recognition of recent diseases and adverse effects of treatments. For instance, recognition of the link between administration of teratogen to mothers and malformations in their babies was suggested by the report of a selected case. Case reports have a task in pharmacovigilance. They will additionally facilitate understand the clinical spectrum of rare diseases, moreover as uncommon presentations of common diseases. They can facilitate generate study hypotheses, as well as plausible mechanisms of disease. Case reports may additionally have a task to play in guiding the personalization of treatments in clinical follow. Therefore it is vital to include case reports in Hematologists conferences

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

 American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for   Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 7: Hematologic Cancers

Hematologic cancer is the mostly spread and most common disorder among other Blood disorders and is a very important aspect of Blood disorder research. Blood malignancies affect the performance and formation of your blood cells. Cancerous cells restrict your blood from performing its important/regular functions, like prohibiting from serious bleeding or fighting with foreign body/infections agents. A chief a part of blood-based investigation goes on during this field. Leukaemia mainly affects the white blood cells (WBCs) and are closely linked to the lymphomas and some of them are deeply related to the adult T cells leukaemia, these disorders comes under the lymph proliferative disorders. The cancer which originates from WBCs (white blood cells) is known as lymphoma and this type of disorder is mainly seen in Hodgkin lymphoma these diseases can be treated with hematopoietic stem cell transplantation, radiation therapy and chemotherapy. The bone marrow in which many white blood cells develop that leads to multiple myeloma.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

 American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for   Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 8: Blood Disorders: Diagnosis and Treatment

For the principle detection of blood disorders, a Physician generally go for Complete blood count (CBC). This is the essential test then to diagnose an individual's blood disease , the doctor usually must do further blood tests Once a doctor/consultant finds that something is wrong with the blood corpuscle types, many additional tests are available for further detection of disease. Doctors can measure proportion of the different types of WBCs (white blood cells) and can also determine subtypes of these cells by assessing certain markers on the surface of the cells. Assessments are made to measure the capacity of white blood cells to fight foreign body/ infection, to evaluate the functioning of blood platelets and their ability to clot and to check the contents of red blood cells to help determine the cause of anaemia or why the cells are not functioning properly. Most of these tests are done on blood samples, but sometime require a bone marrow sample as well for Bone Marrow Examination. Based on the diagnosis, Hematologists choose the apt treatment for specific problem. Present days we've numerous approaches to treat blood malignancies like Chemotherapy, radiotherapy etc. Today’s advanced procedures such as gene therapy is being used to treat Blood ailments. Investigators are endeavouring to search out ways that to correct the defective genes that cause Blood Disorders. Nevertheless, Gene therapy hasn't established to the resolve that it's accepted therapy for blood disease. Though, investigators still take a look at gene therapy in clinical trials. Bone Marrow Transplantation, Hematopoietic stem cell therapy and Cord blood transplantation are new rising varieties of treatment for blood disorders.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 9: Cancer Genomics & Metabolomics

Cancer Genomics & Metabolomics. Cancer genomics is a sub-field of genomics that personifies cancer-linked or cancer associated genes. Whereas Metabolomics is the quantification of small molecules formed by metabolic progressions within a biological model. Metabolomics datasets contain a wealth of data that reflect the disease state and are consequent to both genetic variation and environment. Because cancer is a genomic disease, genomic profiling is an undeniably important tool for precision oncology. Precision Oncology alludes to the fitting of therapeutic cancer treatment to the individual qualities of every patient.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

 American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for   Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 10: Digital Imaging in Hematology

Developments in electronic imaging, computers, and the Internet have given rise to in the speedy emergence of digital imaging in pathology. The Bloodhound system is an instrument that's designed to print blood onto a slide with a controlled method, automatically stain cells, perform a CBC with WBC differential, and locate WBCs by digital imaging, all in an analyser with a footprint of 42 inches. Negligible Hematology Analyzer Plus Blood Smear Digital Imaging/ Analysis make available better Clinical Hematology consequences than a Compound Hematology Analyzer. Digital Imaging works in daily routine for leukocytes in peripheral blood and other fluids, is reliable, accurate and displays a high blast cell sensitity.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

   American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency         for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 11: Organ Specific Cancer

The second foremost basis of death in the world next to cardiovascular diseases is Cancer. Different types of cancers affect diverse organs of the body, roughly of them are Brain cancer, Head and Neck Cancer, Oral cancer, Lung cancer, Breast cancer, Liver cancer, Prostate cancer, Gastric cancer, Pancreatic cancer, Kidney (Renal Cell) cancer, Leukemia and numerous. Most common spots that are influenced by cancer in men are Lung, prostate, colon, rectum, stomach and liver, whereas in women are breast, colon, rectum, lung, cervix and stomach. Aiming cancer metabolism has the likelihood to steer to major advances in cancer healing. Recent developments in diagnosis and therapy of cancers have directed to a rise in cancer survival and hence, there is a greater emphasis on quality beside quantity of survival. Added exploration on the quality-oriented cancer remedies primes to quality-oriented lives in forthcoming. As per the calculations of researchers till now more than 200 types of the cancers have been identified. The menace do subject to, upon the area/Organ involved by Cancer.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

   American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency         for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 12: Hematopoietic Malignancies

Hematopoietic cancers are addressed tumours of system cells. Most of them are encompassed of cells that are functionally heterogeneous with only a subdivision being responsible for tumor care. Leukemias are “liquid tumors” within the blood and are derived from the transformation of either a hematopoietic precursor within the bone marrow or a mature hematopoietic cell within the blood. Leukemias are often lymphoid or myeloid, and acute or chronic. Most hematopoietic malignancies are comprised of cells that are functionally heterogeneous with only a subset being liable for tumor maintenance. The thorough perceptive of accumulation of genetic/epigenetic event progressions could prime to development of therapeutics that more effectively treat hematopoietic malignancies and potentially other cancers. Hematopoietic cancers (HCs) are malignancies of system cells, related to gross chromosomal abnormalities like translocations. Improvements in diagnosis and therapy, including hematopoietic somatic cell transplantation and molecularly targeted strategies, have increased patient survival.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

   American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency         for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 13: Stem Cell Therapy

Stem cell therapy is the treatment where stem cells are used to prevent a disease or condition. Haematopoietic stem cells are usually derived from bone marrow, or peripheral blood. Bone marrow transplantation is widely used stem cell therapy. It may be autologous, allogeneic or syngeneic. Stem cell research deals with research and publication of high-quality manuscripts related to stem cells. Stem cells are cells of multicellular organisms that can differentiate into other types of cells. They can divide more cells of the same type of stem cells. For a cell to be considered a stem cell, it should be self-renewing and must be either totipotent or pluripotent. Various types of stem cells such as embryonic stem cells, foetal and adult stem cells tissue specific stem cells, haemopoietic stem cells, cancer stem cells are known. Haemopoietic stem cells that give rise to other blood cells by a process called Hemopoiesis in the red bone marrow. Haemopoietic stem cell transplants are used in the treatment of cancers and other immune system disorders.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

    American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency          for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 14: Cord Blood Transplantation

One of three foundations of blood-forming cells used in transplants are Cord Blood whereas the other two bases are bone marrow and peripheral blood stem cells. The inoculation of umbilical cord blood to re-establish an individual's own blood production system blocked by anticancer drugs, radiation therapy, or both. Human cryopreserved CD34+ cells from cord blood, bone marrow, and Mobilized blood. CD34+ cells differentiate into all other white blood cells. More Cells. Relevant Results. Types: Cells, Media, Assays. Cancers are often treated through somatic cell transplants, including peripheral blood, bone marrow, and rope blood transplants. The first successful cord blood transplant (CBT) was wiped out 1988 during a child with Fanconi Anemia. The theory of the learning is twofold unit umbilical cord blood transplantation in adults will relate to a one-year endurance rate of at least 40%.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

   American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency         for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 15: Clinical Haematology

It is the branch of medical treatment that deals with identification and therapy of blood ailments and blood malignances. This includes supervision of chemotherapy and transfusion. Clinical Hematology doctors are dealt in the following areas haemato-oncology, haematology and bone marrow transplantation, principal the clinical facilities (Adult & Paediatric) along with a Haemato-Pathologist, auxiliary in hematopathology amenities. Ailments cured under clinical Haematology: Acute Leukemia, Chronic Leukemia, Plasma Cell disorders, Lymphoma – Hodgkin / Non-Hodgkin, Myeloproliferative Neoplasms, Thalassemia and other haemoglobinopathies, All types of coagulation and thrombotic disorders and Haemoglobin and platelet disorders.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

  American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 16: Pediatric Hematology

Paediatric haematology is a branch of haematology dealing with the general haematological problems seen in neonates or paediatric patients. Other issues like blood counts, Polycythaemia, Neonatal anaemia, Anaemia of prematurity, hemolytic anemia within the neonate, Congenital red cell defects, acquired red cell defects, Hyperbilirubinemia, Congenital dyserythropoietic anaemia, Acquired red cell aplasia, Neutropenia, leukaemia etc are dealt under Paediatric Haematology. Haematopoiesis is different in paediatric patients and neonates compared to adults. By birth, virtually all bone marrow cavities are actively hematopoietic. In infantile, haematopoiesis transfers to central bones (vertebrae, sternum, ribs, pelvis). The red cells of the new-born are macrocytic and therefore the blood film from a new-born infant shows macrocytic normochromic cells, polychromasia, and a couple of nucleated red blood cells. Unfluctuating in healthy infants could also be a light anisocytosis and poikilocytosis. Blood viscosity, oxygen delivery, Iron and transferring content, red cell antigens and lots of other features are different in neonates and youngsters compared to the adults. Hence a thorough research enabling a proper diagnosis and treatment of all the haematological disorders in neonates and paediatric patients is highly necessary.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

  American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 17: Haematology and Pharma Industry

The worldwide market of the hematological medications in top point because it is usually anticipated to be enhanced over the few decades. As per the worldwide market expert the hematology medicate and demonstrative market is relied upon to develop at the rate of 7.5% from 2015-2021. Some of the highest pharmacy industries producing Biological Drugs and Generic Drugs incorporate. Takeda oncology, Bristol-Mayers Squibb, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen biotech, Pfizer, Astellas, Bayer, Otsuka, Sanofi, Eisai, AbbVie, Merck KGaA, Pharmacyclics and Incyte.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

  American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 18: Hematology: Diagnostics and Screening

The channel of medicine that perturbed with the learning of the origin, diagnosis, therapy and anticipation of diseases related to blood. It comprises treating diseases that mark the production of blood and its components, for example blood cells, blood proteins, bone marrow, hemoglobin, platelets, spleen, blood vessels and the method of coagulation. Such ailments might embrace hemophilia, blood clots, added bleeding disorders and blood cancers such as leukemia, lymphoma and multiple myeloma. The test center slog that goes into the study of blood is recurrently performed by a medical technologist or medical laboratory scientist. Treating of blood disorder may differ for every particular disorder, this can include use of coagulation factor support, immune modulating therapies, chemotherapy, bone marrow transplantation palliative care must be taken for the patients with complex disorder. Usually, through physical investigations, medical reports are used to spot the ailments by physicians to initiate the best therapy.

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

  American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 19: Biomarkers in Hematology and Oncology

Biomarkers are the biological molecules found in blood, other body fluids, or tissues, which explains a symbol of a normal or anomalous progression, or of a condition or illness. These are used to see how well the body answers to a therapy for an illness or disorder. These are also defined as molecular marker and signature molecule. A cancer biomarker is a gene or substance that detects the occurrence of cancer in the body that are particularly associated with genetic mutations, which determine whether individuals are susceptible to particular type of cancer.

Biomarkers are used in three principal modes in medicine and cancer research:

1. To aid detect complaints in the identification of early phase Malignances

2. To predict how antagonistic an ailment is (Prognostic)

3. To envisage how sound a patient will retort to therapy

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

  American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Track 20: Immunohematology

Immunohematology referred to be blood banking. This is the laboratory medicine dealing up with preparing blood components, blood for appropriate selection and transfusion and also components that are compatible for transfusion which is useful in case of severe blood loss or low blood levels. If the selection and compatibility fail this may directs to harm the kidneys, lungs and might be life threating. Transfusion are often recommended just in case of illness, burns, cancer, injury. Individuals get immunized when there are previous transfusions of blood or in case of pregnancy. Red blood cells contain antigens and protein markers on their surfaces, if recipient or donors red blood cells doesn’t contain this antigen the antigen lacking individual will lead to form antibodies which destroys the red blood cells.so what blood banks screens, typing and cross matching are carried out for blood and its components before the transfusions. If immune system of recipient attacks the donor red blood cells this state knows to be haemolytic reaction. sometimes hives and itching can also be observed

Hematology Conferences | Blood Cancer Conferences | Hematology Meetings | Hematology Oncology Conferences | Hematology European Conferences | Hematological Malignances Conferences

Related Conferences:

5th International Conference on Clinical Hematology and Transfusion Medicine February 24-25, 2021 Rome, Italy ; 18th World Hematology Congress March 16-17, 2021 London, UK; 16th Global Summit on Hematology and Infectious Diseases March 02-03, 2021 London, UK; 12th World Hematology and Oncology Congress March 2- 3, 2021 Edinburgh, Scotland; 10th  Emirates Haematology Conference 19-21 March, 2021; ISH 2021 World Congress 13 - 16 September 2021, Bangkok

European Hematology Societies:

European Society of HematologyBritish Society of HematologyInternational Society of HematologyEuropean Society of Paediatric Hematology OncologySociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:

Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:

American Society of HematologyInternational Society for Laboratory HematologyThe Canadian Hematology SocietyMichigan Society of HematologyAmerican Society of Clinical Oncology

USA Oncology Societies:

  American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for    Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:

Emirates Society of HematologySaudi Society for HematologyHematology Society of Australia and new ZealandMalaysian Society on HematologyAmerican Hematology Association.

European Oncology Societies:

European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

Market Analysis:

Importance and Scope

19th World medicine Congress 2021 accredit to increase the best stage for the aptitudes, explorations, specialists and company ambassadors with its well-planned plug-in covering every moment vision regarding medicine and blood syndromes from the derivation causes behind blood ailments to the foremost best remedies in treating blood disorders and diseases this world congress is to relinquish a revolution for innovative defense against endless disorders like Thalassemia’s, lymphomas, biomarkers in blood and counter acting agents and substance responses and to look at the medical specialty chattels of blood which provides acquaintance regarding the foundation origins.

Market Analysis:

The hematology diagnostics marketplace was esteemed at US$ 3,167.2 million in 2017 and predictable to scope US$ 5,288.3 million by 2026 at a CAGR of 5.9% throughout the prognostication period from 2018 to 2026.

Globally hematology diagnostics marketplace scope was valued at USD 5.96 billion in 2017. It is predicted to increase at a CAGR of 5.85% over the estimate retro. Aspects such as cumulative pervasiveness of blood disorders tied with collective consciousness about these ailments, and presence of classy & cutting-edge technologies are projected to boost the market progress.

Conferring to an artefact issued by Bristol-Myers Squibb, approximately 1 million novel cases of blood malignancy are anticipated to be spotted by 2020, that is estimated to reason for nearly 6.0% of all new-fangled tumors. Besides, a momentous number of the world inhabitants have diverse hemoglobinopathies. High incidence of blood ailments, such that thalassemia is expected to kick the demand for hematology testing.

The advanced investigations in the biomedical segment, exclusively in emerging countries, will boost marketplace development in flow cytometry. Aggregate of radiologists and intensifying attention on the inhibition, and primary diagnosis of ailments will drive the number of medical imaging measures like MRI and CT assessments in hospitals and ASCs across limitless countries. These are predictable to be the chief progress handlers for the global medical imaging components market.

Key Market Movements

  • Global market of hematology diagnostics is increasing at a CAGR of 5.9% for the retro from 2018 to 2026
  • The hematology analyzer sector displays rewarding progress with boosted applications in the diagnostics trade based on the product type.
  • An increasing number of diagnostic centers, availability of automated analysers with enhanced applications, and increasing test volumes will contribute to the overall growth of the hematology diagnostics market
  • Major players in this vertical are Abbott Laboratories, Bio-Rad Laboratories, Inc., Siemens Healthineers, Mindray Medical International Limited, Danaher Corporation, Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Drew Scientific, Sysmex Corporation, EKF Diagnostics, Boule Diagnostics, HORIBA, Diatron MI Zrt. and others

Indian Market:

The Indian hematology devices and components marketplace in 2017 is predictable at `1057 crore, a 11% growth over 2016. Chemicals establish 63.4% of the market. While, substances increased by 11.6% in 2017 over 2016, and devices by 9.9% in rate footings; the growth of 19.1% of instruments in measure rapports was greater in the same retro.

The global hematology analyzer and reagent market is projected to register an impressive expansion at 5.7 percent CAGR during 2018–2024, predicts Persistence Market Research (PMR). In 2017, the market was evaluated at revenues worth USD 1433.43 million, and is estimated to surpass USD 2000 million by the end of 2024. Increasing adoption of automated hematology analyzers, rising technological advancements, and integration of basic flow-cytometry techniques in modern analyzers are some of the key factors driving the growth of the global market. In addition, rising demand for high-throughput hematology analyzers and development of high-sensitivity PoC hematology testing are also fueling the growth of the market.

By 2024, the six-part differential analyzers segment is anticipated to touch USD 230 million on account of a high CAGR of 6.1 percent during 2018–2024. The revenue in the six-part differential segment is poised to rise 1.6× over the years owing to their rising demand mainly because of the quicker pace of innovation seen in the six-part differential segment.

The market for hematology diagnostic devices is expected to increase due to rising support from various private and government organizations. Overview of digital imaging schemes in hematology laboratories and budding practice of microfluidics knowledge in hematology analyzers could produce prospects for the growth of the international hematology diagnostics market. Some of the corporations working in the universal hematology diagnostics market are Abbott Laboratories, Horiba, Hemocue, Beckman Coulter and Siemens Healthcare diagnostics. Other firms comprise Bio-Rad Laboratories, Roche Diagnostics and Nihon Kohden Corporation.

Conferenceseries llc LTD organized the 18th World Hematology Congress.  The conference organized with a focus on “Breezes of transformation and revolution in Hematology” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promote the theme with their elegant talk were:

Bello Jamoh Yusuf- Ahmadu Bello University Teaching Hospital, Nigeria
Donskov SI- Evdokimov Moscow State Medical Dental University, Russia
Ghazala Qamar- Chughtai Institute of pathology, Pakistan

Conferenceseries llc LTD offers well appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries llc LTD and supported the conference in every aspect, without which the conference would not have been possible. Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the success of Hematology 2020,

Conferenceseries llc LTD would like to announce the Webinar on “19th World Hematology Congress” to be held during March 15-16, 2021e. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Hematology Research.

           For more details: https://hematology.insightconferences.com/

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date March 15-16, 2021
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View